About Synfini
Synfini, Inc. is a privately held Menlo Park, California-based pioneer in agile chemistry, spun out of SRI International in 2023. Its AI Cloud Foundry platform combines neuro-symbolic AI, robotic automation, and proprietary chemistry data to accelerate small molecule drug discovery and synthesis. The company serves drug hunters in academia, biotech, and major pharmaceutical companies worldwide.
Company details
Funding
Total raised
$53M
Last stage
Seed
Investors
Founders
Peter Madrid
Ph.D. scientist with 17+ years in chemistry and automation technologies; formerly Head of the Applied Research group of SRI's Biosciences division.
LinkedInDoug Donzelli
Co-founder and Chief Executive Officer of Synfini, Inc., spun out of SRI International in 2023.
Nathan Collins
Ph.D. biotech executive with 25+ years in drug discovery; formerly Chief Strategy Officer at SRI Biosciences.
LinkedInWhat happens next.
No applications, no recruiter spam. Just the intro.
Confirm the fit
A few questions to make sure this role is the right shape for you. Two minutes.
I pitch you to the company
I write the intro, send it to the founder, and handle the back-and-forth.
A meeting lands on your calendar
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.